Olivier C Manintveld
Overview
Explore the profile of Olivier C Manintveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
1109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bierhuizen M, Amesz J, Langmuur S, Lam B, Knops P, Veen K, et al.
Bioengineering (Basel)
. 2025 Feb;
12(2).
PMID: 40001693
Proof-of-concept to determine the direct biomechanical effects of cardiac contractility modulation (CCM) on living myocardial slices (LMS) from patients with end-stage heart failure (HF). Left ventricular LMS from patients with...
2.
Amesz J, Lupgens N, Duncker D, Sluijter-Rozendaal L, Dumay D, Manintveld O, et al.
ASAIO J
. 2025 Feb;
PMID: 39977384
Myocardial edema significantly develops during current subnormothermic ex situ heart perfusion (ESHP) procedures, resulting in myocardial function decline during prolonged perfusion. A relatively high coronary blood flow (CBF) during ESHP...
3.
Kapusta J, Sinnadurai S, Babicki M, Kaluzinska-Kolat Z, Meijers W, Kolat D, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941627
Long COVID symptoms persist globally, with a notable rise in cardiovascular disease (CVD) among COVID-19 survivors, including those without prior risk factors or hospitalizations. This study aims to identify predictors...
4.
van Dijk B, Bos D, Roest S, Hirsch A, Taverne Y, Brugts J, et al.
Transplantation
. 2025 Jan;
PMID: 39841094
Cardiac allograft vasculopathy (CAV) remains a significant challenge after heart transplantation, necessitating effective surveillance methods. This review centers around the role of coronary computed tomography angiography (CCTA) in CAV surveillance,...
5.
Amesz J, Langmuur S, Bierhuizen M, de Groot N, Manintveld O, Taverne Y
J Mol Cell Cardiol Plus
. 2025 Jan;
5():100040.
PMID: 39802172
Heart failure (HF) is a rapidly growing pandemic while medical treatment options remain limited. Omecamtiv mecarbil (OM) is a novel HF drug that directly targets the myosin heads of the...
6.
van Doorn E, Amesz J, Manintveld O, de Groot N, Essers J, Shin S, et al.
Bioengineering (Basel)
. 2025 Jan;
11(12.
PMID: 39768038
Heart failure is characterized by intricate myocardial remodeling that impairs the heart's pumping and/or relaxation capacity, ultimately reducing cardiac output. It represents a major public health burden, given its high...
7.
Amesz J, Bierhuizen M, Langmuur S, Dumay D, Manintveld O, Taverne Y, et al.
Ann Cardiothorac Surg
. 2024 Dec;
13(6):495-501.
PMID: 39649637
Background: Normothermic ex situ heart perfusion (ESHP) has increased the donor pool with hearts donated after circulatory death (DCD), but functional assessment during ESHP using lactate trends is suboptimal. This...
8.
Amesz J, Bierhuizen M, Langmuur S, Knops P, van Steenis Y, Dumay D, et al.
Transpl Int
. 2024 Dec;
37:13279.
PMID: 39635569
Normothermic heart perfusion (ESHP) enables assessment of hearts donated after circulatory death (DCD) prior to transplantation. However, sensitive parameters of cardiac function of DCD hearts on ESHP are needed. This...
9.
The ability of an electronic nose to distinguish between complications in lung transplant recipients
Wijbenga N, Mathot B, van Pel R, Seghers L, Moor C, Aerts J, et al.
Am J Transplant
. 2024 Nov;
PMID: 39571751
Complications like acute cellular rejection (ACR) and infection are known risk factors for the development of chronic lung allograft dysfunction, impacting long-term patient and graft survival after lung transplantation (LTx)....
10.
Zijderhand C, Yalcin Y, Sjatskig J, Bos D, Constantinescu A, Manintveld O, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(11):313.
PMID: 39076441
Background: Right ventricular failure (RVF) is a significant cause of morbidity and mortality in patients with a left ventricular assist device (LVAD). This study is aimed to investigate the influence...